Aseptic Meningoencephalitis in Slovenia
Information source: University Medical Centre Ljubljana
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Aseptic Meningitis
Intervention: symptomatic therapy (Drug); Ceftriaxone or Doxycycline (Drug); questionnaire (Other); Acyclovir (Drug)
Phase: N/A
Status: Recruiting
Sponsored by: University Medical Centre Ljubljana Official(s) and/or principal investigator(s): Franc Strle, MD, PhD, Study Chair, Affiliation: UMC Ljubljana Daša Stupica, MD, PhD, Principal Investigator, Affiliation: UMC Ljubljana
Overall contact: Daša Stupica, MD, PhD, Phone: +386 1 5222110, Email: dasa.stupica@kclj.si
Summary
The main objective of this study is:
- to establish etiology of acute aseptic meningitis/meningoencephalitis in Slovenia
- to assess the clinical course and outcome of tick-borne encephalitis and Lyme
neuroborreliosis
- to characterize the inflammatory proteins, gene polymorphisms, and transcriptome
profiles in patients with tick-borne encephalitis and Lyme neuroborreliosis
Clinical Details
Official title: Prospective Study of the Etiology, Pathogenesis, Clinical Picture and Outcome of Aseptic Meningitis in Slovenia
Study design: Observational Model: Case Control, Time Perspective: Prospective
Primary outcome: Changes in selected clinical parameters in patients with acute aseptic meningitis/meningoencephalitisChanges in selected laboratory parameters in patients with acute aseptic meningitis/meningoencephalitis Changes in selected microbiologic parameters in patients with acute aseptic meningitis/meningoencephalitis
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- clinical picture compatible with aseptic meningitis/meningoencephalitis
- age 18 years or older
- clear cerebrospinal fluid on macroscopic examination
- cerebrospinal pleocytosis (> 5 x 106 white blood cells per liter)
Exclusion Criteria:
- younger than 18 years
- pregnant women
Locations and Contacts
Daša Stupica, MD, PhD, Phone: +386 1 5222110, Email: dasa.stupica@kclj.si
Department of Infectious Diseases, University Medical Center Ljubljana, Ljubljana, Slovenia, Ljubljana 1525, Slovenia; Recruiting Daša Stupica, MD, Phone: +386 1 522 2110, Email: dasa.stupica@kclj.si Franc Strle, MD, Phone: +386 1 5222610, Email: franc.strle@kclj.si Daša Stupica, MD, Principal Investigator Franc Strle, MD, Sub-Investigator
UMC Ljubljana, Department of Infectious Diseases, Ljubljana 1525, Slovenia; Recruiting Daša Stupica, MD, PhD, Phone: +386 1 522 2110, Email: dasa.stupica@kclj.si Franc Strle, MD, PhD, Phone: +386 1 522 2610, Email: franc.strle@kclj.si
Additional Information
Starting date: June 2014
Last updated: December 30, 2014
|